United Kingdom Clinical Trial Supply & Logistics Market Insight
The United Kingdom Clinical Trial Supply & Logistics market size is growing at an 8.02% CAGR, driven by increasing clinical trial activity, rising biologics and personalized medicine demand, and stringent regulatory requirements for drug handling, storage, and distribution. The UK’s strong position in global clinical research, supported by the National Health Service (NHS) and favorable regulatory frameworks, is further accelerating market expansion
United Kingdom Clinical Trial Supply & Logistics Market Insights Forecasts to 2035
- The United Kingdom Clinical Trial Supply & Logistics Market Size Was Estimated at USD 294.4 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 8.02% from 2025 to 2035
- The United Kingdom Clinical Trial Supply & Logistics Market Size is Expected to Reach USD 636.5 Million by 2035
Notable Insights for United Kingdom Clinical Trial Supply & Logistics Market
- By service type, the logistics & distribution segment dominated the market, accounting for approximately 45–50% share in 2024, due to increasing demand for temperature-controlled transportation and global trial coordination.
- By clinical trial phase, Phase III dominated the UK clinical trial supply and logistics market, accounting for approximately 56.9% share in 2024 and contributing around USD 107 million of the total USD 188.2 million market, driven by large-scale multinational trials.
- Approximately 60%+ of clinical trials in the UK involve outsourced supply chain services, driven by demand for efficiency, regulatory compliance, and improved coordination of investigational product distribution across multiple clinical sites.
- Nearly 50% of investigational products in UK clinical trials require cold-chain logistics, particularly for biologics and advanced therapies, while the UK contributes around 10–12% of Europe’s total clinical trial activity.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Clinical Trial Supply & Logistics Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Clinical Trial Supply & Logistics Market
- Thermo Fisher Scientific
- Catalent
- Parexel
- DHL
- UPS Healthcare
- Movianto
- Almac Group
- Others
Recent Developments:
- In April 2026, the UK launched new clinical trial regulations introducing a faster, risk-based approval system, expected to cut approval timelines by 30–40% and enhance clinical research efficiency and competitiveness.
- In March 2025, Almac Group invested in a £65 million UK commercial manufacturing facility to enhance GMP production capacity and strengthen clinical trial supply chain and logistics capabilities.
Market Segmentation:
United Kingdom Clinical Trial Supply & Logistics Market, By Service Type
- Logistics & Distribution
- Packaging, Labelling & Blinding
- Storage & Retention
United Kingdom Clinical Trial Supply & Logistics Market, By Phase
- Phase I
- Phase II
- Phase III
- Phase IV
United Kingdom Clinical Trial Supply & Logistics Market, By Therapeutic Area
- Oncology
- Cardiovascular
- Infectious Diseases
- Neurology
- Others
Expert Views:
The UK Clinical Trial Supply & Logistics Market is expected to witness sustained growth due to increasing clinical trial complexity and demand for biologics requiring specialized handling. Experts highlight that cold-chain logistics, real-time tracking technologies, and integrated supply chain solutions will dominate the market. As decentralized and global trials expand, logistics providers offering end-to-end, compliant, and temperature-controlled services will play a critical role in ensuring efficiency, regulatory adherence, and timely delivery of investigational products.